Primary Care Physicians Identify and Act upon Glycemic Abnormalities Found in Structured, Episodic Blood Glucose Monitoring Data from Non–Insulin-Treated Type 2 Diabetes
Authors:
- 1 May 2009
- journal article
- research article
- Published by SAGE Publications in Diabetes Technology & Therapeutics
- Vol. 11 (5) , 283-291
Abstract
The purpose of this study was to determine if primary care physicians could utilize data collection tools to accurately identify glycemic abnormalities in structured, episodic self-monitoring of blood glucose (SMBG) data from patients with non-insulin-treated type 2 diabetes and whether use of these SMBG data would influence their therapeutic decisions. Twenty-three case studies demonstrating several glycemic states (normoglycemia, elevated fasting glucose, elevated postprandial glucose, all elevated glucose, and hypoglycemia) were presented to 61 primary care physicians who evaluated the cases based upon A1C data, alone and then in combination with SMBG data. SMBG data were presented in five formats. Participants were to identify the specific glucose pattern, determine the necessity for therapy change, and select specific therapeutic changes. Participant assessments were compared with assessments made by a panel of diabetes care specialists. Most (78%) participants identified the same primary blood glucose feature identified by the diabetes specialists; 93.8% agreed with the diabetes care specialists regarding the need for therapy modification. The majority (77%) of participants changed the way they would manage the case after evaluating case studies with SMBG data made available to them. Eighty-six percent of participants considered the SMBG data to be of equal value or more valuable than an A1C test result; 71% of participants strongly agreed that they are now more likely to recommend structured, episodic SMBG to their non-insulin-treated type 2 diabetes mellitus patients. Primary care physicians can correctly identify glycemic abnormalities in SMBG data obtained through structured, episodic SMBG. Additional studies are needed to determine the clinical impact of similar testing regimens in primary care practice settings.Keywords
This publication has 14 references indexed in Scilit:
- Treatment intensification in patients with type 2 diabetesDiabetes, Obesity and Metabolism, 2008
- Efficacy of self monitoring of blood glucose in patients with newly diagnosed type 2 diabetes (ESMON study): randomised controlled trialBMJ, 2008
- Standards of Medical Care in Diabetes—2008Diabetes Care, 2008
- Impact of self monitoring of blood glucose in the management of patients with non-insulin treated diabetes: open parallel group randomised trialBMJ, 2007
- Longitudinal Study of New and Prevalent Use of Self-Monitoring of Blood GlucoseDiabetes Care, 2006
- Assessing Glycemia in Diabetes Using Self-monitoring Blood Glucose and Hemoglobin A1cJAMA, 2006
- Self-monitoring of glucose in type 2 diabetes mellitus:a Bayesian meta-analysis of direct and indirect comparisonsCurrent Medical Research and Opinion, 2006
- Self-monitoring of blood glucose as part of a multi-component therapy among non-insulin requiring type 2 diabetes patients: a meta-analysis (1966–2004)Current Medical Research and Opinion, 2005
- HbA1c determination in patients with hemoglobinopathies.Diabetes Care, 1999
- Postprandial versus Preprandial Blood Glucose Monitoring in Women with Gestational Diabetes Mellitus Requiring Insulin TherapyNew England Journal of Medicine, 1995